1.
Salih SR, Majeed AH, Hussein KM, Yasin YS, Jumaa AH. Dual Drug Repurposing in Cervical Cancer: The Synergistic Cytotoxic Effect of Dapagliflozin-Etoricoxib and Its Predicted Modulation of PI3K/Akt/mTOR Signaling via Molecular Docking. Asian Pac J Cancer Biol [Internet]. 2025 Oct. 26 [cited 2026 Jun. 4];10(4):821-35. Available from: http://waocp.com/journal/index.php/apjcb/article/view/1998